当前位置: X-MOL 学术Neurogastroenterol. Motil. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Microbiota changes induced by microencapsulated sodium butyrate in patients with inflammatory bowel disease.
Neurogastroenterology & Motility ( IF 3.5 ) Pub Date : 2020-05-31 , DOI: 10.1111/nmo.13914
Sonia Facchin 1 , Nicola Vitulo 2 , Matteo Calgaro 2 , Andrea Buda 1 , Chiara Romualdi 3 , Daniel Pohl 4 , Barbara Perini 1 , Greta Lorenzon 1 , Carla Marinelli 1 , Renata D'Incà 1 , Giacomo Carlo Sturniolo 1 , Edoardo Vincenzo Savarino 1
Affiliation  

Butyrate has shown anti‐inflammatory and regenerative properties, providing symptomatic relief when orally supplemented in patients suffering from various colonic diseases. We investigated the effect of a colonic‐delivery formulation of butyrate on the fecal microbiota of patients with inflammatory bowel diseases (IBDs).

中文翻译:

微囊化丁酸钠诱导炎症性肠病患者的微生物群变化。

丁酸盐具有抗炎和再生特性,在患有各种结肠疾病的患者中口服补充时可缓解症状。我们研究了丁酸盐结肠给药制剂对炎症性肠病 (IBD) 患者粪便微生物群的影响。
更新日期:2020-05-31
down
wechat
bug